2007Di-Si Junyi Daxue xuebaoRequires access

Inhibitory effect of hTERT promoter regulated tumor targeting TRALL combined with chemo-radiotherapy on cervical cancer in vivo

Xin Xiao

Open publisher page 0 citations

Abstract

AIM: To study the inhibitory effect of hTERT promoter regulated TRALL combined with chemo-radiotherapy on the growth of transplantation tumor of HeLa cells in nude mice. METHODS: The TRAIL gene activated by the hTERT promoter was transfected into HeLa cells; The GFP protein expression of TRAIL was examined by immunohistochemical staining;The rats were divided into TRAIL gene transfection group,chemotherapy group,radiotherapy group,combined treatment group(genetransfection + chemo-radiotherapy), and control group,with 5 rats in each group.The TRAIL gene transfected cells and the blank HeLa cells were seeded in mice subcutaneously. The combinded effects of TRAIL with chemo-radiotherapy on the nodulation of the cervical cancer HeLa lines were detected. The changes of tumor weight,sizes, and the tumor growth inhibition rate were determined. RESULTS: GFP/TRAIL expression rate was significantly higher in hTERT_TRAIL transfected cells than in control cells(P0.01). Nodulation of HeLa cells was observed on day 5-7 in all group, with no difference in nodulation generation time(P0.05). The transplanted tumor weight was significantly different between transfected hTERT-TRAIL group and control group (P0.05). The transplanted tumors in hTERT-TRAIL grew slowly compared to control group.The tumor growth inhibition rate was 43.08% in hTERT-TRAIL group and 61.63% in the gene transfection plus radio-chemotherapy group at week 4 (P0.01). CONCLUSION: hTERT-TRAIL exerts obvious inhibitory effects on the growth of HeLa cells transplanted tumor in nude mice.The gene transfection plus radio-chemotherapy may enlighten the future preclinical study and clinical therapy for tumors.

About this research paper

What this paper is about

AIM: To study the inhibitory effect of hTERT promoter regulated TRALL combined with chemo-radiotherapy on the growth of transplantation tumor of HeLa cells in nude mice. METHODS: The TRAIL gene activated by the hTERT promoter was transfected into HeLa cells; The GFP protein expression of TRAIL was examined by immunohistochemical staining;The rats were divided into TRAIL gene transfection group,chemotherapy group,radiotherapy group,combined treatment group(genetransfection + chemo-radiotherapy), and control group,with 5 rats in each group.The TRAIL gene transfected cells and the blank HeLa cells were seeded in mice subcutaneously. The combinded effects of TRAIL with chemo-radiotherapy on the nodulation of the cervical cancer HeLa lines were detected. The changes of tumor weight,sizes, and the tumor growth inhibition rate were determined. RESULTS: GFP/TRAIL expression rate was significantly higher in hTERT_TRAIL transfected cells than in control cells(P0.01). Nodulation of HeLa cells was observed on day 5-7 in all group, with no difference in nodulation generation time(P0.05). The transplanted tumor weight was significantly different between transfected hTERT-TRAIL group and control group (P0.05). The transplanted tumors in hTERT-TRAIL grew slowly compared to control group.The tumor growth inhibition rate was 43.08% in hTERT-TRAIL group and 61.63% in the gene transfection plus radio-chemotherapy group at week 4 (P0.01). CONCLUSION: hTERT-TRAIL exerts obvious inhibitory effects on the growth of HeLa cells transplanted tumor in nude mice.The gene transfection plus radio-chemotherapy may enlighten the future preclinical study and clinical therapy for tumors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To study the inhibitory effect of hTERT promoter regulated TRALL combined with chemo-radiotherapy on the growth of transplantation tumor of HeLa cells in nude mice. METHODS: The TRAIL gene activated by the hTERT promoter was transfected into HeLa cells; The GFP protein expression of TRAIL was examined by immunohistochemical staining;The rats were divided into TRAIL gene transfection group,chemotherapy group,radiotherapy group,combined treatment group(genetransfection + chemo-radiotherapy), and control group,with 5 rats in each group.The TRAIL gene transfected cells and the blank HeLa cells were seeded in mice subcutaneously. The combinded effects of TRAIL with chemo-radiotherapy on the nodulation of the cervical cancer HeLa lines were detected. The changes of tumor weight,sizes, and the tumor growth inhibition rate were determined. RESULTS: GFP/TRAIL expression rate was significantly higher in hTERT_TRAIL transfected cells than in control cells(P0.01). Nodulation of HeLa cells was observed on day 5-7 in all group, with no difference in nodulation generation time(P0.05). The transplanted tumor weight was significantly different between transfected hTERT-TRAIL group and control group (P0.05). The transplanted tumors in hTERT-TRAIL grew slowly compared to control group.The tumor growth inhibition rate was 43.08% in hTERT-TRAIL group and 61.63% in the gene transfection plus radio-chemotherapy group at week 4 (P0.01). CONCLUSION: hTERT-TRAIL exerts obvious inhibitory effects on the growth of HeLa cells transplanted tumor in nude mice.The gene transfection plus radio-chemotherapy may enlighten the future preclinical study and clinical therapy for tumors.

Key concepts: Transfection, HeLa, Telomerase reverse transcriptase, Genetic enhancement, Cancer research, Biology, Molecular biology, Telomerase

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibitory effect of hTERT promoter regulated tumor targeting TRALL combined with chemo-radiotherapy on cervical cancer in vivo — Research Paper | ScholarLens